← Back to Search

Low Mindfulness for Forgetfulness

N/A
Waitlist Available
Research Sponsored by Harvard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to find out if noticing instances of forgetting leads to a decline in memory performance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Brief Test of Adult Cognition by Telephone with Stop-and-Go Switch Task (BTACT; (Tun & Lachman, 2006)
Everyday Memory Questionnaire-Revised (EMQ-R; Royle & Lincoln, 2008)
Memory Controllability Inventory (MCI; Lachman, Bandura, Weaver, & Elliott, 1995)
+1 more
Secondary study objectives
Image of Aging Scale (Levy, Kasl, & Gill, 2004).
Langer Mindfulness Scale (LMS-14; Pirson, Langer, Bodner, & Zilcha, 2012)
Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Low MindfulnessExperimental Treatment1 Intervention
All participants in this condition will complete all measures online and over the phone at two points in time, including one narrative response at T1. They will also be instructed to respond to diary-type text messaging questions (some related to memory performance) twice daily for six days.
Group II: High MindfulnessExperimental Treatment1 Intervention
All participants in this condition will complete all measures online and over the phone at two points in time, including one narrative response at T1. They will also be instructed to complete a mindfulness intervention at home and respond to diary-type text messaging questions (all including questions about memory performance) twice daily for six days.
Group III: Active controlActive Control1 Intervention
All participants in this condition will complete all measures online and over the phone at two points in time, including one narrative response at T1. They will also be instructed to respond to diary-type text messaging questions (none about memory performance) twice daily for six days.

Find a Location

Who is running the clinical trial?

Harvard UniversityLead Sponsor
233 Previous Clinical Trials
473,721 Total Patients Enrolled
~29 spots leftby Nov 2025